[South China Morning Post]Chinese researchers to test double doses of CanSino’s coronavirus vaccine candidate
Researchers plan to start a clinical trial for an additional dose of a coronavirus vaccine candidate co-developed by China’s CanSino Biologics and a military-backed research unit, according to a clinical trial registry.A single dose of the vaccine candidate Ad5-nCoV, one of a handful that China is pursuing, has final-stage ...